Science
A new service designed to support early-phase therapeutic programs with scientific due diligence and strategic risk assessment.
Located in central France, the Baugy facility specializes in in vivo, in silico and in vitro studies to support product development. It plays a central role in delivering GLP-compliant services across ERBC’s integrated drug and chemical development platforms.
